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Abstract
Transforming growth factor-b (TGF-b) plays a pivotal role in renal fibrosis. Endoglin, a 180 KDa membrane glycoprotein, is a
TGF-b co-receptor overexpressed in several models of chronic kidney disease, but its function in renal fibrosis remains
uncertain. Two membrane isoforms generated by alternative splicing have been described, L-Endoglin (long) and S-
Endoglin (short) that differ from each other in their cytoplasmic tails, being L-Endoglin the most abundant isoform. The aim
of this study was to assess the effect of L-Endoglin overexpression in renal tubulo-interstitial fibrosis. For this purpose, a
transgenic mouse which ubiquitously overexpresses human L-Endoglin (L-ENG+) was generated and unilateral ureteral
obstruction (UUO) was performed in L-ENG+ mice and their wild type (WT) littermates. Obstructed kidneys from L-ENG+ mice
showed higher amounts of type I collagen and fibronectin but similar levels of a-smooth muscle actin (a-SMA) than
obstructed kidneys from WT mice. Smad1 and Smad3 phosphorylation were significantly higher in obstructed kidneys from
L-ENG+ than in WT mice. Our results suggest that the higher increase of renal fibrosis observed in L-ENG+ mice is not due to
a major abundance of myofibroblasts, as similar levels of a-SMA were observed in both L-ENG+ and WT mice, but to the
higher collagen and fibronectin synthesis by these fibroblasts. Furthermore, in vivo L-Endoglin overexpression potentiates
Smad1 and Smad3 pathways and this effect is associated with higher renal fibrosis development.
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Introduction
Chronic kidney disease (CKD) is a pathology that affects nearly
10% of the population. This illness is characterized by a
progressive decrease in glomerular filtration rate that eventually
leads to renal failure. Tubulointerstitial fibrosis, a major determi-
nant of CKD, occurs by myofibroblast activation and proliferation
in the renal interstitium with accumulation of extracellular matrix
(ECM) [1].
One of the most important molecules related with renal fibrosis
is transforming growth factor b (TGF-b) being TGF-b1 the most
studied isoform [2,3]. Two receptors, type I (TbRI) and type II
(TbRII) are necessary for TGF-b signaling. Whereas there is only
one type II receptor for TGF-b1, two type I receptors have been
described, Activin Like Kinase Receptor 1 and 5 (ALK1 and
ALK5, respectively), which phosphorylate the specific Smads.
Thus, TGF-b is able to signal through ALK1-Smad1/5 or ALK5-
Smad2/3 pathways, resulting in different cell responses [4]. It is
traditionally accepted that TGF-b1 exerts its profibrotic effects
through the ALK5 pathway [5]. However, Smad1 pathway
activation has been recently associated with renal fibrosis in
diabetic and obstructive nephropathy [6,7]. Endoglin (Eng), a 180
KDa-homodimeric transmembrane glycoprotein, acts as co-
receptor of some members of the TGF-b superfamily [8]. In vitro
experiments have shown that endoglin antagonizes the profibrotic
effect of TGF-b [9,10]. It has been also observed that endoglin is
overexpressed in several experimental models of renal fibrosis such
as renal mass reduction [11], unilateral ureteral obstruction
(UUO) [12] and in radiation-induced fibrosis [13]. Moreover,
endoglin involvement has been studied in other fibrotic patholo-
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gies such as scleroderma [14], hepatic fibrosis [15] or cardiac
fibrosis [16,17].
Endoglin presents two membrane isoforms called L-Endoglin
(long) and S-Endoglin (short). These isoforms, described in human
and mice, are produced by alternative splicing and differ from
each other in the length of their cytosolic tails (shorter in S-
Endoglin) [18,19]. As L-Endoglin is the most abundant isoform
[8], we have focused our study on the effect of the overexpression
of this isoform in renal fibrosis.
The unilateral ureteral obstruction (UUO) model of obstructive
nephropathy reproduces the most representative features of
tubulointerstitial fibrosis: extracellular matrix (ECM) accumula-
tion, tubular apoptosis, myofibroblast activation and proliferation,
tubular deletion and inflammatory cell infiltration, and it has been
used in multiple studies to assess the mechanisms involved in these
processes [20]. The aim of the present study was to elucidate the
effect of L-Endoglin overexpression in renal fibrosis induced by
UUO.
Materials and Methods
Generation and characterization of L-ENG+ transgenic
mice
To generate a transgenic mice expressing human L-endoglin (L-
ENG+), HA-tagged L-endoglin cDNA in pDisplay [21] and L-
endoglin cDNA in pCEXV [18] were used to derive by PCR a
construct encoding the endoglin leader sequence (amino acids 1–
25) followed by the influenza hemagglutinin epitope (HA; Tyr-
Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala) and the mature L-endoglin
(variant 1, amino acids 26–658). The resulting 2.3-kb cDNA
fragment was cloned into the EcoRI site of pcEXV vector [18].
The L-endoglin-pcEXV vector was digested with EcoRI, and the
endoglin fragment was inserted into the EcoRI site of the
pCAGGS plasmid [22] under the control of a ubiquitous actin
promoter. The pCAGGS plasmid contains, from 59 to 39, a CMV
enhancer, a chicken enhancer and promoter, a b-globin intron, an
EcoRI site, and a b-globin polyadenylation motif [23]. To obtain
linear DNA fragments for microinjection, the expression vector L-
endoglin-pCAGGS was digested with SalI/KpnI and the endoglin
containing 5.2-kb fragment was separated by agarose gel
electrophoresis. The purified fragment (Figure 1a) was microin-
jected into CBAxC57BL/6J fertilized eggs at the University of
Salamanca Transgenic Facility, using standard protocols. Progeny
was screened for endoglin transgene by PCR of tail DNA using
forward (59-AGAGCATCCTCCTCCGACTGG-39) and reverse
(59-TGAAGCCACGAATGTTTTTCT-39) primers. L-ENG+
transgenic founders were crossed with C57BL/6J mice to
perpetuate the transgenic lines. Three independent transgenic
founders were generated and similar phenotypic features were
observed in all the derived transgenic lines. Mice were kept in a
pathogen-free facility for genetically modified animals (Servicio de
Experimentacio´n Animal, SEA; University of Salamanca).
Mice and animal disease
A breeding colony of adult L-ENG+ animals has been
maintained in our facilities for more than 2 years. Studies were
performed in the 6th–7th generation of backcrossing. All studies
were performed in parallel in L-ENG+ and WT male mice aged 8
weeks. The UUO procedure was performed as previously
described [12,24]. In brief, mice were anesthetized with isofluor-
ane (Schering-Plough, Madrid, Spain), the abdomen was opened
and the left ureter was located and occluded in two places with
non-absorbable 5-0 silk. The abdomen was closed with running
suture and the skin was closed with interrupted sutures. After
surgery, animals were kept warm during 3 hours and a single dose
of analgesic (buprenorphine, Schering-Ploug, Madrid, Spain) was
injected subcutaneously to enhance the post-operation phase.
Sham-operated (SO) animals were included as controls. Subse-
quently, mice were housed in a temperature-controlled room with
a 12 h light/dark cycle and fed on standard chow (Panlab,
Barcelona, Spain) and water ad libitum. UUO was maintained
during 15 days.
Figure 1. Transgenic mice expressing human L-endoglin. (a) Schematic representation of the DNA construct used to generate transgenic mice
expressing human L-endoglin. A 5.2-kb SalI/KpnI fragment, containing a CMV enhancer, an actin enhancer/promoter, a b-globin (BG) intron (fragment
SalI/EcoRI), the endoglin leader sequence-LS, the hemagglutinin epitope-HA, the human L-endoglin cDNA (fragment EcoRI/EcoRI) and a b-globin
polyadenylation site-polyA (fragment EcoRI/KpnI), was microinjected in the pronuclei of fertilized oocytes to generate L-ENG+ mice. The transcription
start site (TSS) and the translation initiation of the open reading frame (ORF) are indicated. (b) Expression of human L-endoglin protein in different
tissues from L-ENG+ mice. Protein extracts were analyzed by western blot using anti-endoglin and anti-HA antibodies. (c) Effects of human L-endoglin
overexpression in systolic arterial blood pressure (SABP). N = 12 mice per group.
doi:10.1371/journal.pone.0110365.g001
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All the studies were approved by the Animal Care and Use
Committees of the University of Salamanca and mice were cared
in compliance with the rules of European Union and with the US
Department of Health and Human Services Guide for the Care
and Use of Laboratory Animals.
Blood pressure measurement
Before performing UUO, blood pressure was recorded in
conscious L-ENG+ and WT mice (n = 12 in each group) with an
automated multichannel system by using the tail-cuff method and
a photoelectric sensor (Niprem 546; Cibertec, Madrid, Spain).
Animals were previously accustomed for several days and
measures were collected at the same hour during at least 3 days.
Kidney sampling
Euthanasia was performed with i.p. pentobarbital overdose.
Animals were perfused from the heart with heparinized saline
solution. For histological studies, obstructed (O) and non
obstructed (NO) kidneys were removed [WT: SO (n = 3); NO
(n = 4); O (n = 4) and L-ENG+: SO (n = 3); NO (n = 4); O (n = 4)],
halved, and fixed in 4% buffered formalin for 24 h. Subsequently,
kidneys were dehydrated in ascending series of ethanol, cleared in
Figure 2. Effect of L-Endoglin overexpression on interstitial
fibrosis after unilateral ureteral obstruction (I). Representative
images of haematoxylin-eosin (a) and Masson’s trichrome (b) staining in
sham operated (SO), non-obstructed (NO) and obstructed (O) kidneys
from WT and L-ENG+ mice. In O kidneys tubular dilatation, inflammatory
cell infiltration and interstitial fibrosis can be observed. Bar = 100 mm.
doi:10.1371/journal.pone.0110365.g002
Figure 3. Effect of L-Endoglin overexpression on interstitial
fibrosis after unilateral ureteral obstruction (II). (a) Representa-
tive images of Sirius Red staining in sham operated (SO), non-
obstructed (NO) and obstructed (O) kidneys from WT and L-ENG+ mice.
Bar = 100 mm. (b) Morphometric quantification (mean 6 SEM) of area
stained by Sirius Red; SO (n = 3); NO (n = 4); O (n = 4) in each group of
mice. *P,0.05 vs. their respective SO kidneys. #P,0.05 vs. O kidneys
from WT mice.
doi:10.1371/journal.pone.0110365.g003
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xylene and embedded in paraffin. Kidney sections (3 mm) were
stained with either hematoxylin-eosin or Masson’s trichrome for
light microscopy analysis, as previously described [12,24]. The
other half was immediately frozen used for protein and mRNA
obtention.
Morphometric studies
For image analysis of fibrosis, additional 5-mm thick renal
sections were cut, mounted on glass slides and stained with Sirius
red (Direct Red 80, Sigma-Aldrich Quimica, Madrid, Spain) to
evaluate the area occupied by collagen fibers. From each kidney, a
total of 15 interstitial images of each slide were captured and
processed with a high-resolution video camera (Sony, DF-W-
X710) connected to a light microscope (Nikon Eclipse 50i) using
the 20x objective and a green optical filter (IF 550). The area
occupied by collagen was measured using a computerized image
analysis system (Fibrosis HRR, Master Diagnostic), as described
[25]. The values obtained were expressed in square micrometers.
Immunohistochemistry studies were quantified by using ImageJ
software (Rasband, W.S., ImageJ, National Institutes of Health,
Bethesda, Maryland, USA). Ten images per slide were digitalized
and processed with the same video camera and microscope
described for the analysis of fibrosis.
Immunohistochemical studies
Three mm sections were processed for immunohistochemistry as
follows. Endogenous peroxidase was blocked with 3% hydrogen
peroxide and immunohistochemical staining for fibronectin
(F3648, 1:100 dilution; Sigma-Aldrich, St Louis, MO, USA),
collagen I (Ab21286, 1:800; Abcam, MA, USA), a-SMA (A2547,
1:1,000; Sigma-Aldrich, St Louis, MO, USA and NCL-MSA
1:200; Leica Microsistemas, Barcelona, Spain), phospho-Smad2/3
(sc-11769, 1:50 dilution; Santa Cruz Biotechnology Inc, CA, USA)
and phospho-Smad1 (Ab63439, 1:50 dilution; Abcam, Cam-
bridge, UK) were performed. Then, sections were washed three
times in PBS and incubated with the Novolink Polymer Detection
Figure 4. Effect of L-Endoglin overexpression on fibronectin and collagen I expression following ureteral obstruction. Representative
immunohistochemistry images for fibronectin (a) and collagen I (b) in sham operated (SO), non-obstructed (NO) and obstructed (O) kidneys from WT
and L-ENG+ mice. Bar = 100 mm. Western blot analysis of fibronectin (c) and collagen I (d) protein amount in SO, NO and O kidneys from WT and L-
ENG+ mice. A representative western blot among 5–7 performed in each group is shown on top. Densitometry analysis is represented as the mean6
SEM of the 5–7 western performed per group. *P,0.01 vs. SO kidneys. #P,0.05 vs. O kidneys from WT mice.
doi:10.1371/journal.pone.0110365.g004
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System (Novocastra, MA, USA), followed by reaction with
3,39diaminobenzidine as chromogen. Negative WT slides were
prepared without primary antibody.
Western blot and PCR analysis
For western blot, after euthanasia with i.p. pentobarbital
overdose, SO, NO and O kidneys were removed from wild type
and L-ENG+ mice [WT: SO (n = 5); NO (n = 7); O (n = 7) and L-
ENG+: SO (n = 5); NO (n = 7); O (n = 7)] and immediately stored
at 280uC. Tissue protein extracts were prepared as previously
described [12]. Total kidney protein lysates were fractioned by
SDS-PAGE, transferred onto PVDF membrane (Millipore Bill-
erica, MA, USA) and incubated overnight at 4uC with the
following antibodies: anti-fibronectin (AB2033, 1:1,000 dilution;
Chemicon International, Temecula, CA, USA), anti-collagen type
I (Ab765P, 1:1,000 dilution; Chemicon International, Temecula,
CA, USA), anti-a-SMA (A2547, 1:1,000; Sigma-Aldrich, St Louis,
MO, USA), anti-Smad1 (sc-7965, 1:1,000 dilution; Santa Cruz
Biotechnology, CA, USA), Smad2/3 (sc-6032, 1:1,000 dilution;
Signaling Technology, MA, USA), anti-phospho-Smad1 (06-702,
1,1000, 1:1,000 dilution; Abcam, Cambridge, UK), anti-phospho-
Smad2 (566415, 1:1,000 dilution; Calbiochem, La Jolla, CA,
USA), anti-phospho-Smad3 (9520, 1:1,000 dilution; Cell Signaling
Technology Inc., Danvers, MA, USA), anti-GAPDH (AM4300,
1:40,000 dilution; Invitrogen, CA, USA), and anti-endoglin
(human) (sc-20632, 1:1,000 dilution; Santa Cruz Biotechnology,
CA, USA). Membranes were washed and incubated with the
corresponding secondary antibodies (1:10,000 dilution; Bio-Rad,
St Louis, MO, USA) for 45 minutes. Development was performed
using a chemiluminescent reagent (ECL detection reagent,
Amersham Biosciences) and signals were recorded on X-ray film
(Fujifilm), followed by densitometric analysis using ImageJ
software (Rasband, W.S., ImageJ, National Institutes of Health,
Bethesda, Maryland, USA).
Total protein normalization to GAPDH was not performed
since this loading control varies after UUO, as it has been
described by other authors [26,27,28]. However, we have included
the GAPDH blot in order to demonstrate that the increases in
protein expression observed after UUO and the higher increased
expression observed in L-ENG+ animals is not due to an increase
of housekeeping proteins.
For RT-PCR analysis, total RNA was isolated using Nucleospin
RNAII (Macherey-Nagel), according to the manufacturer’s
instructions. Single-strand cDNA was generated from 2 mg of
total RNA using poly-dT as primer with M-MLV reverse
transcriptase (Promega). Quantitative RT-PCR was performed
in triplicate. Each 20 ml reaction contained 1 ml of cDNA, 400 nM
of each primer, and 1x iQ SybrGreen Supermix (Bio-Rad).
Standard curves were run for each transcript to ensure exponential
amplification and to rule out non-specific amplification. Primers
used were: For mouse Collagen Ia: forward 59-GGAGAGAG-
CATGACCGATGGA-39 and reverse 59-GGTGGACATTAG-
GCGAGGAA-3. For mouse Fibronectin: forward 59-TGACAG-
TTGGTCACCCTGTT-39 and reverse 59-GGTGTCTGGG-
TGACTTTCCT -39. For mouse PRS13 (120 bp): forward 59-
GATGCTAAATTCCGCCTGAT-39 and reverse 59-TAGAG-
CAGAGGCTGTGGATG-39. Cycling conditions for Fibronectin
and PRS13: 95uC, 5 min, 35 cycles of 1 min 95uC, 1 min 59uC
and 1 min 72uC, and an elongation cycle of 5 min 72uC. Cycling
conditions for Collagen Ia: 95uC, 5 min, 35 cycles of 1 min 95uC,
1 min 56uC and 1 min 72uC, and an elongation cycle of 5 min
72uC. Gene expression was normalized to RPS13 expression. The
reactions were run on an iQ5 Real-time PCR detection system
(Bio-Rad).
Figure 5. Effect of L-Endoglin overexpression on myofibroblast
abundance following ureteral obstruction. Representative immu-
nohistochemistry images for a-SMA (a) in sham operated (SO), non-
obstructed (NO) and obstructed (O) kidneys from WT and L-ENG+ mice.
Bar = 100 mm. (b) Quantification of a-SMA-positive stained area in sham
operated (SO), non-obstructed (NO) and obstructed (O) kidneys from
WT and L-ENG+ mice, expressed as square microns. (c) Western blot
analysis of a-SMA protein amount in SO, NO and O kidneys from WT
and L-ENG+ mice. A representative western blot among 5–7 performed
in each group is shown on top. Densitometry analysis is represented as
the mean 6 SEM of the 5–7 western performed per group. *P,0.01 vs.
SO kidneys. #P,0.05 vs. O kidneys from WT mice.
doi:10.1371/journal.pone.0110365.g005
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Renal fibroblast culture
Renal fibroblasts were obtained from a pool of animals (3 per
group) in which UUO was maintained during 3 days, as previously
described [7]. In brief, kidneys were removed and washed with
saline solution (NaCl 0.9%) and Dulbecco solution (2.6 mM KCl,
1.5 mM KH2PO4, 137 mM NaCl, 8 mM Na2HPO4, 5.6 mM
glucose) supplemented with 500 U/mL penicillin/streptomycin.
Kidneys were cut in thin slices (,0.2 mm) and embedded in a
0.45 mg/L collagenase type IA solution (Sigma-Aldrich, St Louis,
MO, USA) during 40 minutes at 37uC. Tissue culture superna-
tants containing fibroblasts were placed in Dulbecco’s modified
Eagle’s medium (Gibco, Life Technologies, Carlsbad) containing
10% fetal calf serum and 100 U/mL penicillin/streptomycin at
37uC in the presence of 5% CO2. In the third passage, when
cultures achieved 80–90% confluence, cells were serum starved for
24 h before performing the experiments. Cells were treated with
human TGF-b1 1 ng/mL (R&D Systems, Minneapolis, MN,
USA) for 30 minutes in order to analyze Smad signaling as it has
been described [29] or during 24 hours to analyze protein
expression, as previously described [30,31].
Cell immunofluorescence
Fibroblasts seeded in cover slips were fixed with 4% formalin
washed with PBS, permeabilized with 0.1% Triton X-100,
blocked for 30 min with 2% BSA in PBS, treated with PBS-
0.05% Tween 20 for 10 min, and incubated during 2 hours with
anti a-SMA antibody or Oregon Green (Invitrogen) for total actin
detection. Then, cells were incubated for 30 min with goat anti-
mouse Cy3 (1:1,000 dilution; Jackson Immuno-Research, West
Grove PA, USA) in PBS in a dark chamber. For nuclei staining,
incubation with 2 mM Hoechst 33258 (Molecular Probes,
Barcelona, Spain) for 5 min in a dark chamber was performed.
Cover slips were mounted on slides using Prolong gold antifade
(Molecular Probes). Confocal images were obtained as previously
described [24].
Figure 6. Effect of L-Endoglin overexpression on Smad1 and phospho-Smad1 expression following ureteral obstruction. (a)
Representative immunohistochemistry images for phospho-Smad1 in sham operated (SO), non-obstructed (NO) and obstructed (O) kidneys from WT
and L-ENG+ mice. Bar = 100 mm. (b) Histogram representing the number of phospho-Smad1-positive nuclei per field in SO, NO and O kidneys from WT
and L-ENG+ mice. Data is represented as mean6 SEM. Western blot analysis of phospho-Smad1 (c) and total Smad1 (d) protein amount in SO, NO and
O kidneys from WT and L-ENG+ mice. A representative western blot among 5–7 performed in each group is shown on top. Densitometry analysis is
represented as the mean 6 SEM of the 5–7 western performed per group. *P,0.01 vs. SO kidneys. #P,0.05 vs. O kidneys from WT mice.
doi:10.1371/journal.pone.0110365.g006
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Statistical analysis
Data are expressed as mean 6 standard error of the mean
(SEM). Comparison of means was performed by one way analysis
of variance (ANOVA). Data was analyzed using the GraphPad
Prism 5. A p-value lower than 0.05 was considered statistically
significant.
Results
Characterization of L-ENG+ transgenic mice
A transgenic mice expressing human L-endoglin (L-ENG+)
under the control of a ubiquitous actin promoter was generated
(Figure 1a). Protein levels of human L-Endoglin were evaluated in
several tissues as lung, liver, spleen and heart by Western blot
analysis (Figure 1b). Our results show that human L-Endoglin is
expressed in all organs studied being this expression higher in
heart and spleen. Human L-Endoglin band appears also in human
tissues, as expected (Figure S1). Mice of three independent founder
lines appeared healthy and were of the same size and weight as
their non-transgenic littermates. They were fertile, showing a
normal ratio of male to female littermates, had a normal lifespan,
and they did not show notable changes in microscopic structures of
the major organs (data not shown). Haemodynamic studies
revealed that WT and L-ENG+ mice have a similar systolic
arterial blood pressure (Figure 1c), thus discarding hypertension as
a possible risk factor to develop renal damage in these animals.
Effects of L-ENG overexpression on renal collagen and
fibronectin after UUO
After 15 days of UUO, obstructed kidneys in both, wild type
and L-ENG+ mice, exhibited a severe hydronephrosis and the
typical features of obstructive nephropathy. Thus, both hematox-
ylin-eosin and Masson’s trichrome staining revealed that the total
thickness of the cortex and medulla was diminished and medullar
compression was evidenced (Figure S2). In the cortex, tubules
Figure 7. Effect of L-Endoglin overexpression on Smad2/3 and phospho-Smad3 expression following ureteral obstruction. (a)
Representative immunohistochemistry images for phospho-Smad3 in sham operated (SO), non-obstructed (NO) and obstructed (O) kidneys from WT
and L-ENG+ mice. Bar = 100 mm. (b) Histogram representing number of nuclei positively stained for phospho-Smad3 per field in SO, NO and O kidneys
from WT and L-ENG+ mice. Data is represented as mean6 SEM. Western blot analysis of phospho-Smad3 (c) and total Smad2/3 (d) protein amount in
SO, NO and O kidneys from WT and L-ENG+ mice. A representative western blot among 5–7 performed in each group is shown on top. Densitometry
analysis is of the 5–7 western performed per group. *P,0.01 vs. SO kidneys. #P,0.05 vs. O kidneys from WT mice.
doi:10.1371/journal.pone.0110365.g007
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showed changes ranging from a dilated lumen with a flattened
epithelium to necrosis of varying degrees. In most cases, an
interstitial inflammatory infiltrate was observed, mainly in
perivascular areas (Figure 2a). Fibrosis, detected with Masson’s
trichrome staining, was irregularly distributed and more pro-
nounced around blood vessels. Little or no tissue fibrosis was
observed in non obstructed (NO) kidneys as compared with
obstructed (O) kidneys. Obstructed kidneys from L-ENG+ mice
had a high degree of fibrosis, according to Masson’s staining, than
WT mice. Sham-operated animals had normal kidney histology
(Figure 2b). Sirius red staining showed that O kidneys from L-
ENG+ mice had a high degree of fibrosis compared to O kidneys
from WT mice (Figure 3a, b). Morphometric studies performed in
Sirius red-stained slides demonstrated that O kidneys from L-
ENG+ mice had more renal area occupied by fibrosis than O
kidneys from WT mice (Figure 3b).
Both collagen I and fibronectin abundance, assessed by
immunohistochemistry and western blot, showed an increased
amount of these proteins in O respect to those of NO kidneys
(Figure 4). Immunohistochemistry studies revealed that kidneys
from sham-operated animals and NO kidneys from WT mice
showed a weak expression of fibronectin relegated to the basement
membranes. Collagen I was practically absent in kidneys from
sham animals and in NO kidneys from WT, but was slightly
present in NO kidneys from L-ENG+ mice (Figure 4a). Staining
for collagen I and fibronectin proteins in the interstitial space of O
kidneys from L-ENG+ mice was higher than in O kidneys from
WT animals (Figure 4a, b). Similar results were obtained after
western blot analysis. Thus, the amount of collagen-I and
fibronectin in O kidneys from L-ENG+ mice was significantly
higher than in O kidneys from WT animals (Figure 4c, d).
Moreover, qPCR analysis showed an increase in both collagen I
and fibronectin mRNA expression after UUO. This increase was
slightly higher in L-ENG+ than in WT mice but the difference was
not statistically significant (Figure S3).
Effects of L-ENG overexpression on myofibroblast
abundance after UUO
Myofibroblasts are a major source of extracellular matrix
proteins and its presence is a hallmark of renal fibrosis [27]. To
assess whether the different degree in renal fibrosis between O
kidneys of L-ENG+ and WT mice was due to differences in
myofibroblast abundance, this parameter was evaluated by
measuring the content of a-SMA, a specific protein for myofibro-
blasts [32]. Immunostaining analysis revealed that, whereas a-
SMA expression is limited to vessel walls in NO and sham kidneys,
a strong expression in the renal interstitium was observed in O
kidneys, without apparent differences between O kidneys from L-
ENG+ and wild type mice (Figure 5a). The quantification of a-
SMA-positive stained areas showed a similar increase in both WT
and L-ENG+ O kidneys. Assuming that the stained area is
proportional to the number of myofibroblasts, we can suggest that
the increase in myofibroblast number was similar in both groups of
animals (Figure 5b). In addition, western blot analysis revealed
that O kidneys showed a higher a-SMA expression than NO
kidneys, whereas no significant differences in a-SMA content
between O kidneys from L-ENG+ and WT animals were observed
(Figure 5c).
Figure 8. Effect of L-Endoglin overexpression on ECM synthesis
in renal fibroblasts. (a) Immunofluorescence of human L-Endoglin
and a-SMA in WT and L-ENG+ renal fibroblasts. Magnification, 1,000X.
Note the presence of human L-endoglin only in L-ENG+ renal
fibroblasts. (b) Effect of L-Endoglin on ECM protein levels in renal
fibroblasts. Representative western blot analysis of fibronectin, collagen
I, human L-Endoglin and GAPDH proteins in WT and L-ENG+ renal
fibroblasts under basal conditions and after TGF-b1 (1 ng/mL)
treatment for 24 hours. Densitometric analysis is represented as the
mean 6 SEM. *P,0.01 vs. WT fibroblasts in basal conditions. #P,0.05
for TGF-b1 treatments vs. basal conditions. sP,0.05 for TGF-b1
treatment in L-ENG+ vs. TGF-b1 treatment in WT fibroblasts.
doi:10.1371/journal.pone.0110365.g008
Endoglin and Renal Fibrosis
PLOS ONE | www.plosone.org 8 October 2014 | Volume 9 | Issue 10 | e110365
Effects of L-ENG overexpression in the TGF-b/Smad
signalling pathway
It is well know that TGF-b promotes fibrosis activating specific
downstream Smad proteins. To elucidate how L-ENG overex-
pression contributes to increased renal fibrosis, we assessed Smad1
and Smad3 phosphorylation by measuring the abundance of p-
Smad1 and p-Smad3 by western blot and immunohistochemistry.
Immunohistochemistry for p-Smad1 showed a clear nuclear
localization of this protein in both interstitial and tubular nuclei,
expression that is mostly detected in O kidneys (Figure 6a).
Accordingly, the number of p-Smad1-stained nuclei was higher in
L-ENG+ than in WT mice (Figure 6b). Sham animals exhibited a
weak p-Smad1 signal, circumscribed to nuclei of interstitial cells.
Moreover, immunohistochemistry for p-Smad2/3 also revealed a
remarkably higher p-Smad2/3 expression in O kidneys as
compared with NO and sham kidneys (Figure 7a).
Western blot analysis showed that levels of p-Smad1 and p-
Smad3 were higher in O than in NO or sham kidneys, being these
levels significantly higher in O kidneys from L-ENG+ than in those
from WT animals (Figures 6c and 7c). Total Smad2/3 and total
Smad1 expression was also assessed by western blot. While there
was no difference in total Smad1 content between all the groups
(Figure 6d), Smad2/3 levels were higher in O kidneys from L-
ENG+ than in O kidneys from WT mice (Figure 7d).
L-Eng overexpression increases ECM production in renal
fibroblasts in vitro
With the aim to evaluate whether L-Endoglin overexpression
influences the activity of fibroblasts, renal fibroblasts from L-
ENG+ and wild type mice were isolated and cultured. Both L-
ENG+ and WT-derived fibroblasts were a-SMA positive (Fig-
ure 8a). L-ENG was detected in L-ENG+2, but not in WT-
derived fibroblasts (Figure 8a, b). The fibrogenic potential of L-
ENG+ fibroblasts was assessed by measuring collagen I and
fibronectin production. Western blot analysis revealed that
collagen I and fibronectin production was significantly higher in
L-ENG+ fibroblasts than in wild type fibroblasts (Figure 8b, c).
Treatment with 1 ng/mL TGF-b1 induced an increase of collagen
I and fibronectin expression in WT fibroblasts. However, this
increase was not observed in L-ENG+ fibroblasts after treatment
with TGF-b1 (Figure 8b, c).
Effects of L-ENG overexpression on the TGF-b/Smad
signalling pathway in renal fibroblasts
Western blot analysis showed that basal Smad1 and Smad3
phosphorylation were higher in L-ENG+ than in WT fibroblasts.
Treatment with 1 ng/mL TGF-b1 for 30 min increased Smad2
and Smad3 phosphorylation, but not Smad1 phosphorylation in
WT and L-ENG+ fibroblasts. Moreover, TGF-b1-induced Smad2
Figure 9. Effect of L-Endoglin overexpression on TGF-b1/Smad signalling in renal fibroblasts. (a) Representative western blot analysis of
phospho-Smad1, phospho-Smad2, phospho-Smad3, Smad2/3, Smad1 and GAPDH protein expression in WT and L-ENG+ renal fibroblasts under basal
conditions and after TGF-b1 (1 ng/mL) treatment for 30 minutes. (b) Densitometric analysis is represented as the mean 6 SEM. *P,0.01 vs. WT
fibroblasts in basal conditions. #P,0.05 for TGF-b1 treatment vs. basal conditions.
doi:10.1371/journal.pone.0110365.g009
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and Smad3 phosphorylation was higher in L-ENG+ than in WT
fibroblasts (Figure 9a, b).
Discussion
Our results suggest that L-Endoglin overexpression is associated
to increased renal fibrosis after UUO mainly due to the enhanced
ability of renal myofibroblasts to synthesize ECM components.
In previous studies, we have observed that endoglin expression
was increased in different experimental models of renal fibrosis
[11,33]. Furthermore, endoglin haploinsufficiency does not seem
to affect the fibrosis induced in the UUO model [12]. As the
expression of the different membrane endoglin isoforms was not
assessed in those experiments, and it has been reported that L- and
S-Endoglin show distinct modulatory effects on TGF-b signaling
[8,29], the contribution of endoglin and its isoforms to renal
fibrosis remains unclear. In this study, our aim has been to
evaluate if the overexpression of L-Endoglin, the predominant
endoglin isoform, modulates renal fibrosis after UUO. Our results
show that both total renal fibrosis, assessed by Masson’s trichrome
and Sirius red staining, and expression of collagen I and
fibronectin, two major components of ECM, were higher in
obstructed kidneys from L-ENG+ than those from WT mice.
qPCR analysis showed an increase in both collagen I and
fibronectin mRNA expressions after UUO, and this increase was
slightly higher in L-ENG+ than in WT mice but the difference was
not statistically significant. This can be explained because 15 days
after UUO, most of ECM is already synthesized and deposited in
the kidney and actual ECM components synthesis is very low.
Myofibroblasts abundance is a major feature of renal fibrosis
[1]. Several authors have proposed a-SMA as a reliable
myofibroblast marker [34]. Our results show that the amount of
a-SMA in the obstructed kidneys, assessed by either WB or
immunohistochemistry, was similar in L-ENG+ and wild type
mice, thus suggesting that the abundance of myofibroblasts was
similar in the obstructed kidneys of both strains.
Our results are in agreement with several authors that have
shown a profibrotic role of endoglin in different fibrotic contexts
such as kidney after irradiation [13] and heart after thoracic aorta
constriction [17]. Although a role for endoglin in ECM down
regulation had been previously suggested, this conclusion was
obtained mainly from in vitro studies [9,10,29,35,36,37].
TGF-b is able to signal through ALK1 or ALK5, leading to
phosphorylation of Smad1/5 or Smad2/3, respectively
[4,29,36,38]. It has been observed that UUO induces an increase
in Smad2 and Smad3 phosphorylation [39], and the contribution
of TGF-b/Smad2/3 pathway in renal fibrosis have been
extensively studied [5,40,41,42,43]. Our results of WB and
immunohistochemistry show that Smad3 activation increases in
obstructed kidneys from both WT and L-ENG+ mice, but this
increase is higher in L-ENG+ than in WT mice. This result
suggests that the increased fibrosis observed in obstructed kidneys
from L-ENG+ mice may be related with a higher Smad3
phosphorylation. In addition, immunohistochemistry studies
revealed that this increase was located in cells placed in the
tubular interstitium but not in tubular cells, suggesting that higher
Smad2/3 phosphorylation does not seem to be related with
changes in epithelial cell function but with changes in interstitial
cells, presumably fibroblasts.
The contribution of Smad1/5 pathway in fibrosis is controver-
sial. While several authors have shown that this pathway is
antifibrotic when is induced by BMP-7 [44,45], others have shown
a pro-fibrotic role, especially in diabetic nephropathy [46,47,48]
and also in dermal sclerosis [49]. In this study we have observed
that overexpression of L-Endoglin not only potentiates phosphor-
ylation of Smad2/3, but also of Smad1, as phospho-Smad1
increase observed in obstructed kidneys was higher in L-ENG+
than in WT mice. Our study shows that increased phospho-Smad1
immunostaining in L-ENG+ mice is located in the tubular
interstitium, suggesting that L-Endoglin overexpression is associ-
ated with Smad1 activation in renal myofibroblasts, and that the
activation of this pathway may enhance ECM protein synthesis by
these cells, as postulated by some authors [14,49].
Cultured renal myofibroblasts overexpressing L-Endoglin syn-
thesize more collagen I and fibronectin under basal conditions,
probably due to a higher Smad1, Smad2 and Smad3 phosphor-
ylation in these conditions. However, treatment with TGF-b1
(1 ng/mL) induced an increase of collagen type I and fibronectin
in wild type, but not in L-ENG+ renal fibroblasts. This lack of
TGF-b1-induced fibrotic response may be due to the higher
Smad2 phosphorylation observed in L-ENG+ fibroblasts. Anti-
fibrotic role of Smad2 activation has been described in Smad2 KO
mouse embryo fibroblasts [50].
In conclusion, we have shown that overexpression of L-
Endoglin increases renal fibrosis following UUO, suggesting its
active participation in this pathological process. This effect may be
explained by a higher L-Endoglin-dependent Smad1 and Smad3
phosphorylation. The increase in renal fibrosis observed in L-
ENG+ mice is not due to a higher number of myofibroblasts, but a
higher ability of myofibroblasts in the kidney of these animals to
synthesize ECM proteins.
Supporting Information
Figure S1 Human L-Endoglin expression in different
tissues. Expression of human L-Endoglin (hENG) in heart,
spleen, lung, liver and kidney tissues from L-ENG+ mice. No
expression of the protein is detected in WT mice. Human lung (A)
and human cervical paraganglioma (B) biopsies were used as
positive control of L-Endoglin expression. GAPDH was used as
load control.
(TIF)
Figure S2 Effect of unilateral ureteral obstruction in
renal cortex and medulla thickness. Low amplification
images of non-obstructed (NO) and obstructed kidneys (O) stained
with (a) hematoxilin-eosin and (b) Masson’s trichrome. Blue line:
thickness of the cortex. Black bar: 1 mm. Note the marked
decrease in cortex and medulla thickness in O kidneys.
(TIF)
Figure S3 Effect of L-Endoglin overexpression on colla-
gen Ia and fibronectin mRNA expression after unilateral
ureteral obstruction. mRNA for collagen Ia (a) and fibronectin
(b) in sham operated (SO), non-obstructed (NO) and obstructed
(O) kidneys from WT and L-ENG+ mice were analyzed by RT-
PCR. PRS13 was used as housekeeping gene. Number of mice in
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